Non-Hodgkin's Lymphomas, version 3.2012.

Published

Journal Article

These NCCN Guidelines Insights summarize several key updates to the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas (NHL) and describe the clinical evidence supporting the updates. The featured updates include changes to the recommendations for treatment options in patients with chronic lymphocytic leukemia (including in elderly or frail patients and patients with poor-risk cytogenetics), guidance surrounding surveillance imaging for follow-up of patients with NHL, and the addition of first-line consolidation options for patients with mantle cell lymphoma.

Full Text

Duke Authors

Cited Authors

  • Zelenetz, AD; Wierda, WG; Abramson, JS; Advani, RH; Andreadis, CB; Bartlett, N; Bellam, N; Byrd, JC; Czuczman, MS; Fayad, L; Glenn, MJ; Gockerman, JP; Gordon, LI; Harris, NL; Hoppe, RT; Horwitz, SM; Kelsey, CR; Kim, YH; Krivacic, S; LaCasce, AS; Nademanee, A; Porcu, P; Press, O; Pro, B; Reddy, N; Sokol, L; Swinnen, L; Tsien, C; Vose, JM; Yahalom, J; Zafar, N; Naganuma, M; Dwyer, MA

Published Date

  • December 1, 2012

Published In

Volume / Issue

  • 10 / 12

Start / End Page

  • 1487 - 1498

PubMed ID

  • 23221787

Pubmed Central ID

  • 23221787

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2012.0155

Language

  • eng

Conference Location

  • United States